Skip to main content
Clinical Trials/NL-OMON51794
NL-OMON51794
Not yet recruiting
Not Applicable

Validation of a finger prick capillary blood sampling test for home monitoring of C-reactive protein and therapeutic drug monitoring of biological therapy in patients with inflammatory bowel disease - FiP-HOME-IBD

niversitair Medisch Centrum Groningen0 sites64 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
64
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- An established diagnosis of Crohn's disease (CD) or ulcerative colitis (UC)
  • \- Receiving biological induction or maintenance therapy according to standard
  • treatment protocols
  • \- 18 years of age or older
  • \- Written and signed informed consent

Exclusion Criteria

  • \- Patients with a visual, physical or mental impairment, rendering them unable
  • to use a capillary sampling device.
  • \- Patients unable to read or understand the Dutch language
  • \- Patients with severe Raynaud\*s syndrome or digital ischemia
  • \- Unwillingness to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials